Scientists discover differences in the blood samples of seve
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Researchers have identified proteins in the blood of COVID-19 patients which are linked to the disease severity, an advance that may lead to markers that provide information on the progression of their illness, according to a study published in the journal Cell Systems

• The scientists used state-of-the-art analytical techniques to rapidly determine the levels of various proteins in the plasma component of COVID-19 patient blood samples.

• Analyzed blood plasma samples from 31 men and women who were receiving treatment at Charité for COVID-19 of varying degrees of severity.

• Identified 27 proteins in the blood which varied in quantity depending on disease severity.

• However, the biomarkers identified by the researchers also included clotting factors and regulators of inflammation.

• Some of these proteins act on interleukin 6 (IL-6) at the molecular level. IL-6 is a protein that is known to cause inflammation, and which, according to preliminary studies, is associated with severe COVID-19 symptoms.

• A number of the biomarkers identified as part of this study might, therefore, be suitable targets for treatment.

• Ralser said an early blood test would enable the treating physician to predict whether or not a patient with COVID-19 will develop severe symptoms.

Source: https://www.sciencedaily.com/releases/2020/06/200605121516.htm
G●●●●●i V●●●●●a and 2 other likes this1 share
Like
Comment
Share